Navigation on swissre.com
Our applied research covers emerging risks, industry trends and topical deep dives.
Topics & Risk Dialogues
Our events examine topics relevant to understanding risk and re/insurance.
No time to wait
COP26 – Insurance leadership in ...
Feeling the heat
With selected research partners, we explore the future of risk coverage, assess changes in the risk landscape and act as a catalyst for industry change.
Meetings of the Swiss Re Strategic Council explore emerging issues and provide strategic insights, advice and recommendations on the global economic, political, regulatory ...
Superior research driving better decisions.
26 Oct 2021
Swiss Re Institute
Content Type: Blog
In early 2020, there were two big medical questions that we all had: "Just when will we have a vaccine?" and "How can we treat ...
By Adam Strange, Life & Health R&D Analyst, Swiss Re Institute
15 Sep 2021
Christoph Nabholz, Chief Research Officer, Swiss Re Institute, spent time with Ángel Gurría, secretary-general of OECD, ...
By Christoph Nabholz, Chief Research Officer, Swiss Re Institute
03 May 2021
Content Type: Blog
April 2021 marked the highest daily COVID death tolls in India and Brazil. Insurers will need to have a forward-looking view on ...
By Prachi Patkee, Life & Health R&D Analyst, Swiss Re Institute
26 Mar 2021
COVID-19 has made the value of life more palpable but life insurance sales have not seen an increase since the pandemic started.
By Julien Descombes, CEO elipsLife
11 Mar 2021
As news of a new virus spreading in China emerged in January 2020, my team and I found ourselves asking: "How bad will this get?"
By Lawrence Tsui, Chief Pricing Officer L&H Products, Life & Health Products
08 Mar 2021
Early on in the pandemic we had no understanding of the behavior of the disease.
By Nicola Charlton, UW R&D Senior Medical Officer, Life & Health Products
02 Mar 2021
Rapid action early on saves lives and reduces economic disruption – so in the future we must act faster.
By Stephen Kramer, Emerging Risks Research Lead, Swiss Re Institute
24 Feb 2021
Vaccines and new stimulus will give economies a growth boost, but the pandemic recovery is not a structural recovery - yet.
By Jerome Jean Haegeli, Group Chief Economist, Swiss Re Institute
18 Feb 2021
The worldwide impact of COVID-19 is staggering: over 100 million cases, more than 300 million tests performed in the US alone, ...
15 Feb 2021
Late last year, as many of us again shut our doors and stayed home, we placed our hope on the COVID-19 vaccines to help us return ...
By Francesca Tamma, Head Behavioural Research, Swiss Re Institute